Subtle variations in Pten dose determine cancer susceptibilityAndrea Alimonti, Pier Paolo Pandolfi, John G. Clohessy et al.|Nature Genetics|2010Cited by 579
Aberrant <i>Rheb</i>-mediated mTORC1 activation and <i>Pten</i> haploinsufficiency are cooperative oncogenic eventsCaterina Nardella, Pier Paolo Pandolfi|Genes & Development|2008Cited by 117